Denville, NJ, United States of America

Mukteeshwar Gande

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mukteeshwar Gande: Innovator in Pharmaceutical Formulations

Introduction

Mukteeshwar Gande is a notable inventor based in Denville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of oral dosage forms. His innovative work focuses on improving the bioavailability of metaxalone, a medication used to treat muscle spasms.

Latest Patents

Mukteeshwar Gande holds a patent for "Reduced dose metaxalone formulations." This patent describes oral dosage forms of metaxalone that exhibit improved bioavailability in both fed and fasted states. The formulations allow for a reduced dose based on the enhanced bioavailability, which can lead to more effective treatment options for patients.

Career Highlights

Gande is associated with Primus Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical formulations. His work has contributed to advancements in medication delivery systems, enhancing patient outcomes through innovative approaches.

Collaborations

His coworker, Robert M Levy, has collaborated with Gande on various projects, contributing to the development of new pharmaceutical formulations.

Conclusion

Mukteeshwar Gande's contributions to the field of pharmaceuticals, particularly through his patent on metaxalone formulations, highlight his role as an innovator in improving medication efficacy. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…